Bezafibrate Therapy
Bezafibrate Therapy is a pharmacotherapeutic intervention belonging to the class of fibrates, distinguished by its application in the management of cholestatic liver diseases through the modulation of bile acid metabolism and anti-inflammatory effects mediated via peroxisome proliferator-activated receptor (PPAR) activation.
295
Publications
17.1K
Citations
1.5K
Authors
482
Institutions
Publications per year
2017–2026
34
295
1–5 of 295
1.5K
17
h-index
17
h-index
17
h-index
14
h-index
14
h-index
1–5 of 1.5K
482

Sheba Medical Center
Ramat Gan, Israel
26 h-index
181 publications
15.6K citations

Tel Aviv University
Tel Aviv, Israel
20 h-index
112 publications
8.1K citations
Wolfson Medical Center
Holon, Israel
14 h-index
91 publications
11.2K citations
Kissei Pharmaceutical (Japan)
Matsumoto, Japan
8 h-index
27 publications
2.5K citations
The University of Tokyo
Tokyo, Japan
7 h-index
44 publications
1.9K citations

Karolinska University Hospital
Stockholm, Sweden
7 h-index
20 publications
1.1K citations
Inserm
Paris, France
7 h-index
48 publications
21.2K citations
Shinshu University
Matsumoto, Japan
7 h-index
29 publications
1.2K citations
1–8 of 482
Repository · 16 publications · 451 citations
13
h-index
15 publications · 497 citations
13
h-index
JLR · 8 publications · 426 citations
8
h-index
8 publications · 439 citations
8
h-index
8 publications · 415 citations
8
h-index
1–5